Wednesday, March 2, 2022

Single dose innovation - PharmaTimes

Take gene therapy, for example: the first one for spinal muscular atrophy (SMA), Zolgensma, was approved in the US in May 2019 and in Europe in ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...